البحث عن طبيب

Allison C. Rosenthal, D.O.

  1. Hematologist
  2. Internist
  3. Oncologist
طلب موعد

المنشورات

  1. Tun AM, Wang Y, Maliske S, Micallef I, Inwards DJ, Habermann TM, Porrata L, Paludo J, Bisneto JV, Rosenthal A, Kharfan-Dabaja MA, Ansell SM, Nowakowski GS, Farooq U, Johnston PB. Autologous Stem Cell Transplant in Fit Patients With Late Relapsed Diffuse Large B-Cell Lymphoma That Responded to Salvage Chemotherapy. Transplant Cell Ther. 2024 Oct; 30 (10):1001.e1-1001.e12 Epub 2024 July 10
    View PubMed
  2. Saifi O, Breen WG, Lester SC, Rule WG, Stish BJ, Rosenthal A, Munoz J, Lin Y, Bansal R, Hathcock MA, Johnston PB, Ansell SM, Paludo J, Khurana A, Villasboas JC, Wang Y, Iqbal M, Alhaj Moustafa M, Murthy HS, Ayala E, Kharfan-Dabaja MA, Hoppe BS, Peterson JL. Outcomes of patients with R/R B-cell NHL and limited (<5 sites) pre-CART disease bridged with or without radiotherapy. Blood Adv. 2024 Sep 24; 8 (18):4877-4885
    View PubMed
  3. Tun AM, Patel RD, St-Pierre F, Ouchveridze E, Niu A, Thordardottir T, Obasi J, Rosenthal A, Pophali PA, Fenske TS, Karmali R, Ahmed S, Johnston PB. Anti-CD19 chimeric antigen receptor T-cell therapy in older patients with relapsed or refractory large B-cell lymphoma: A multicenter study. Am J Hematol. 2024 Sep; 99 (9):1712-1720 Epub 2024 June 04
    View PubMed
  4. Zheng-Lin B, Kelemen K, Rosenthal A. A Case of Gastric Thickening and a Large Ovarian Mass. JAMA Oncol. 2024 Sep 1; 10 (9):1282-1283
    View PubMed
  5. Khurana A, Rosenthal AC, Mohty R, Gaddam M, Bansal R, Hathcock MA, Nedved AN, Durani U, Iqbal M, Wang Y, Paludo J, Villasboas JC, Dingli D, Kourelis T, Leung N, Alkhateeb H, Ruff MW, Gallo de Moraes A, Vergidis P, Herrmann J, Kenderian SS, Bennani NN, Johnston PB, Ansell SM, Lin Y. Chimeric antigen receptor T-cell therapy associated hemophagocytic lymphohistiocytosis syndrome: clinical presentation, outcomes, and management. Blood Cancer J 2024 Aug 12; 14 (1):136
    View PubMed
  6. Okcu I, Wang Y, Bock AM, Zhou J, Moustafa MA, Tun HW, Rosenthal AC, Johnston PB, Baidoun F, Khurana A, Kabat BF, King RL, Habermann TM, Nowakowski GS. Incidence of Central Nervous System Relapse in Primary Mediastinal Large B-Cell Lymphoma: Implications for Central Nervous System Prophylaxis. Clin Lymphoma Myeloma Leuk. 2024 Aug 2 Epub 2024 Aug 02
    View PubMed
  7. Tun AM, Wang Y, Maliske S, Micallef I, Inwards DJ, Habermann TM, Porrata L, Paludo J, Bisneto JV, Rosenthal A, Kharfan-Dabaja MA, Ansell SM, Nowakowski GS, Farooq U, Johnston PB. Autologous stem cell transplant in fit patients with refractory or early relapsed diffuse large B-cell lymphoma that responded to salvage chemotherapy. Haematologica. 2024 Jul 1; 109 (7):2186-2195 Epub 2024 July 01
    View PubMed
  8. Laughlin BS, Van Der Walt C, Mangold AR, Breen WG, Rosenthal AC, Lester S, Hoppe B, Peterson J, Bogan A, Rule WG. Fine-Tuning Low-Dose Total Skin Electron Therapy for Optimal Management of Cutaneous T-Cell Lymphoma: A Comparative Analysis of Regimens. Adv Radiat Oncol. 2024 Jul; 9 (7):101502 Epub 2024 Mar 24
    View PubMed
  9. Bi L, Rosenthal AC, Kuo PH, Yang M. Physiologic (18)F-FDG Uptake in Brown Adipose Tissue and Lactating Breast in a Patient with Hodgkin Lymphoma. J Nucl Med Technol. 2024 Jun 5; 52 (2):177-178 Epub 2024 June 05
    View PubMed
  10. Monick S, Rosenthal A. Circulating Tumor DNA as a Complementary Prognostic Biomarker during CAR-T Therapy in B-Cell Non-Hodgkin Lymphomas. Cancers (Basel). 2024 May 15; 16 (10)
    View PubMed
  11. Laughlin BS, Zaniletti I, Foster MG, Lucido J, Mangold AR, Rosenthal AC, VAN DER Walt C, Breen W, Lester S, Hoppe B, Petersen J, Armstrong MD, Bogan A, Rule WG. Tailoring Radiation Therapy for Patients With Limited Cutaneous T Cell Lymphoma: Preliminary Clinical Experience With Subtotal Skin Electron Therapy. Anticancer Res. 2024 Apr; 44 (4):1491-1497
    View PubMed
  12. Gurney M, Baranwal A, Rosenthal A, Kharfan-Dabaja MA, Kenderian SS, Lin Y, Shah MV. Features and Factors Associated With Myeloid Neoplasms After Chimeric Antigen Receptor T-Cell Therapy. JAMA Oncol. 2024 Apr 1; 10 (4):532-535
    View PubMed
  13. Iqbal M, Jagadeesh D, Chavez J, Khurana A, Rosenthal A, Craver E, Epperla N, Li Z, Isufi I, Awan FT, Dholaria BR, Maakaron JE, Sandoval-Sus JD, Mishra R, Saha A, Annunzio K, Bhaskar ST, Sumransub N, Fijalka A, Ivanov SA, Lin Y, Kharfan-Dabaja MA. Efficacy of CD19 directed therapies in patients with relapsed or refractory large b-cell lymphoma relapsing after CD19 directed chimeric antigen receptor T-cell therapy. Bone Marrow Transplant. 2024 Feb; 59 (2):211-216 Epub 2023 Nov 16
    View PubMed
  14. Saifi O, Lester SC, Breen WG, Rule WG, Lin Y, Bennani NN, Rosenthal A, Munoz J, Murthy HS, Kharfan-Dabaja MA, Peterson JL, Hoppe BS. Incorporating radiation with anti-CD19 chimeric antigen receptor T-cell therapy for relapsed/refractory non-Hodgkin lymphoma: A multicenter consensus approach. Am J Hematol. 2024 Jan; 99 (1):124-134 Epub 2023 Nov 11
    View PubMed
  15. Ramsower CA, Rosenthal A, Robetorye RS, Mwangi R, Maurer M, Villa D, McDonnell T, Feldman A, Cohen JB, Habermann T, Campo E, Clot G, Buhler MM, Kulis M, Martin-Subero JI, Gine E, Cook JR, Hill B, Raess PW, Beiske KH, Reichart A, Hartmann S, Holte H, Scott D, Rimsza L. Evaluation of clinical parameters and biomarkers in older, untreated mantle cell lymphoma patients receiving bendamustine-rituximab. Br J Haematol. 2024 Jan; 204 (1):160-170 Epub 2023 Oct 25
    View PubMed
  16. Gaulin C, Craig F, Fortin Ensign S, Robetorye R, Gibson S, Kelemen K, Khera N, Leis J, Tsang M, Rosenthal A, Munoz J, Palmer J, Hilal T. Allogeneic hematopoietic stem cell transplantation in adults with dendritic/histiocytic neoplasms. Leuk Lymphoma 2023 Dec; 64 (14):2347-2350 Epub 2023 Sept 07
    View PubMed
  17. Jacobson CA, Rosenthal AC, Arnason J, Agarwal S, Zhang P, Wu W, Amber V, Yared JA. A phase 2 trial of defibrotide for the prevention of chimeric antigen receptor T-cell-associated neurotoxicity syndrome. Blood Adv. 2023 Nov 14; 7 (21):6790-6799
    View PubMed
  18. Rosenthal A, Duvall A, Kahn J, Khan N. Disparities in care and outcomes for adolescent and young adult lymphoma patients. EJHaem. 2023 Nov; 4 (4):934-939 Epub 2023 Sept 27
    View PubMed
  19. Saifi O, Breen WG, Lester SC, Rule WG, Stish BJ, Rosenthal A, Munoz J, Lin Y, Bansal R, Hathcock MA, Johnston PB, Ansell SM, Paludo J, Khurana A, Villasboas JC, Wang Y, Iqbal M, Moustafa MA, Murthy HS, Kharfan-Dabaja MA, Peterson JL, Hoppe BS. Consolidative radiotherapy for residual fluorodeoxyglucose activity on day +30 post CAR T-cell therapy in non-Hodgkin lymphoma. Haematologica. 2023 Nov 01; 108(11):2982-2992.
    View PubMed
  20. Besch JG, Kechter J, Hwang A, Shahin A, Bhullar P, Puri P, Butterfield R, Costello C, Rule W, Rosenthal A, DiCaudo DJ, Pittelkow M, Mangold A. Primary cutaneous diffuse large B-cell lymphoma, leg type, presenting as subcutaneous nodules: Case series and comparison of treatment outcomes. JAAD Case Rep. 2023 Nov; 41:81-84 Epub 2023 Sept 26
    View PubMed
  21. Saifi O, Breen WG, Lester SC, Rule WG, Stish BJ, Rosenthal A, Munoz J, Lin Y, Bansal R, Hathcock MA, Bennani NN, Paludo J, Khurana A, Villasboas JC, Johnston PB, Ansell SM, Iqbal M, Moustafa MA, Murthy HS, Kharfan-Dabaja MA, Hoppe BS, Peterson JL. Don't Put the CART Before the Horse: The Role of Radiation Therapy in Peri-CAR T-cell Therapy for Aggressive B-cell Non-Hodgkin Lymphoma. Int J Radiat Oncol Biol Phys. 2023 Aug 1; 116 (5):999-1007 Epub 2022 Dec 21
    View PubMed
  22. Wiedmeier-Nutor JE, Iqbal M, Rosenthal AC, Bezerra ED, Garcia-Robledo JE, Bansal R, Johnston PB, Hathcock M, Larsen JT, Bergsagel PL, Wang Y, Reeder CB, Leis JF, Fonseca R, Palmer JM, Gysbers BJ, Mwangi R, Warsame RM, Kourelis T, Hayman SR, Dingli D, Kapoor P, Kumar SK, Durani U, Villasboas JC, Paludo J, Bennani NN, Nowakowski G, Ansell SM, Castro JE, Kharfan-Dabaja MA, Lin Y, Vergidis P, Murthy HS, Munoz J. Response to COVID-19 Vaccination Post-CAR T Therapy in Patients With Non-Hodgkin Lymphoma and Multiple Myeloma. Clin Lymphoma Myeloma Leuk. 2023 Jun; 23 (6):456-462 Epub 2023 Mar 07
    View PubMed
  23. Chohan KL, Young JR, Lester S, Moustafa MA, Rosenthal A, Tun HW, Hoppe BS, Johnston PB, Micallef IN, Habermann TM, Ansell SM. End-of-treatment PET in early-stage Hodgkin lymphoma: valuable in addition to interim PET. Haematologica 2023 Jun 1; 108 (6):1697-1701 Epub 2023 June 01
    View PubMed
  24. Huntington SF, Schuster SJ, Ding W, Koehler AB, Brander DM, Rosenthal AC, Leis JF, Tun HW, Alhaj Moustafa M, Moustafa MA, Iqbal M, He W, Kearney AS, McKinlay TP, Gui M, Mato AR. DTRMWXHS-12, a novel Bruton tyrosine kinase inhibitor, in combination with everolimus and pomalidomide in patients with relapsed/refractory lymphomas: An open-label, multicenter, phase 1a/1b study. Am J Hematol. 2023 May; 98 (5):739-749 Epub 2023 Mar 07
    View PubMed
  25. Bezerra ED, Iqbal M, Munoz J, Khurana A, Wang Y, Maurer MJ, Bansal R, Hathcock MA, Bennani N, Murthy HS, Rosenthal AC, Paludo J, Villasboas JC, Johnston PB, Habermann TM, Ansell SM, Castro JE, Witzig TE, Kharfan-Dabaja MA, Nowakowski GS, Lin Y. Barriers to enrollment in clinical trials of patients with aggressive B-cell NHL that progressed after CAR T-cell therapy. Blood Adv. 2023 Apr 25; 7 (8):1572-1576
    View PubMed
  26. Tun AM, Wang Y, Matin A, Inwards DJ, Habermann TM, Micallef I, Johnston PB, Porrata L, Paludo J, Bisneto JV, Rosenthal A, Tun HW, Cerhan JR, Witzig TE, Nowakowski GS, Ansell SM. Outcomes of Patients With Classic Hodgkin Lymphoma Who Relapsed After Autologous Stem Cell Transplant. Hemasphere. 2023 Apr; 7 (4):e869 Epub 2023 Apr 04
    View PubMed
  27. Loveday T, Duns G, Rimsza LM, Rech KL, Cook JR, Robetorye RS, Rosenthal AC, Ramsower CA, Yip TK, McKinney CL, Swerdlow SH, Bhavsar S, Steidl C, Gibson SE. Transformation of FL into DLBCL with a PMBL gene expression signature. Blood Adv. 2023 Mar 28; 7 (6):893-899
    View PubMed
  28. Rosenthal AC, Munoz JL, Villasboas JC. Clinical advances in epigenetic therapies for lymphoma. Clin Epigenetics. 2023 Mar 4; 15 (1):39 Epub 2023 Mar 04
    View PubMed
  29. Borcherding N, Severson KJ, Henderson N, Ortolan LS, Rosenthal AC, Bellizzi AM, Liu V, Link BK, Mangold AR, Jabbari A. Single-cell analysis of Sezary syndrome reveals novel markers and shifting gene profiles associated with treatment. Blood Adv. 2023 Feb 14; 7 (3):321-335
    View PubMed
  30. Forero-Forero JV, Lengerke-Diaz PA, Moreno-Cortes E, Melody M, Rahman ZA, Rosenthal AC, Kharfan-Dabaja MA, Castro JE. Predictors and Management of Relapse to Axicabtagene Ciloleucel in Patients with Aggressive B-cell Lymphoma. Hematol Oncol Stem Cell Ther. 2023 Jan 17; 16(2):133-143.
    View PubMed
  31. Garcia-Robledo JE, Valencia-Sanchez C, Knox MG, Goodman BP, Rosenthal AC, Patel B, Castro JE. It Is in the Eye of the Beholder: Ocular Ultrasound Enhanced Monitoring of Neurotoxicity after CAR-T Cell Therapy. Hematol Rep. 2022 Dec 29; 15(1):1-8.
    View PubMed
  32. Fortin Ensign SP, Gaulin C, Hrachova M, Ruff M, Harahsheh E, Vicenti K, Castro J, Munoz J, Rosenthal A, Mrugala MM. Evaluating the Patient with Neurotoxicity after Chimeric Antigen Receptor T-cell Therapy. Curr Treat Options Oncol. 2022 Dec; 23 (12):1845-1860 Epub 2022 Dec 16
    View PubMed
  33. Granroth G, Rosenthal A, McCallen M, Coughlin C, Benson H, Palmer J, Castro JE, Munoz J. Supportive Care for Patients with Lymphoma Undergoing CAR-T-cell Therapy: the Advanced Practice Provider's Perspective. Curr Oncol Rep. 2022 Dec; 24 (12):1863-1872 Epub 2022 Nov 07
    View PubMed
  34. Soumerai JD, Rosenthal A, Harkins S, Duffy J, Mecca C, Wang Y, Grewal RK, El-Jawahri AR, Liu H, Menard C, Dogan A, Yang L, Rimsza LM, Bantilan K, Martin H, Lei M, Mohr S, Kurilovich A, Kudryashova O, Postovalova E, Nardi V, Abramson JS, Chiarle R, Zelenetz AD, Louissaint A Jr. Next-generation ALK inhibitors are highly active in ALK-positive large B-cell lymphoma. Blood. 2022 Oct 20; 140 (16):1822-1826
    View PubMed
  35. Iqbal M, Bansal R, Yassine F, Gandhi S, Rosenthal A, Moustafa MA, Li Z, Craver EC, Mohty R, Murthy H, Ayala E, Tun H, Munoz J, Castro J, Lin Y, Kharfan-Dabaja MA. Impact of Rituximab and Corticosteroids on Late Cytopenias Post-Chimeric Antigen Receptor T Cell Therapy. Transplant Cell Ther. 2022 Oct; 28 (10):668.e1-668.e6 Epub 2022 July 14
    View PubMed
  36. Tun AM, Maliske S, Wang Y, Inwards DJ, Habermann TM, Micallef I, Porrata L, Paludo J, Bisneto JV, Rosenthal A, Kharfan-Dabaja MA, Ansell SM, Nowakowski GS, Farooq U, Johnston PB. Progression-Free Survival at 24 Months as A Landmark After Autologous Stem Cell Transplant in Relapsed or Refractory Diffuse Large B-cell Lymphoma. Transplant Cell Ther. 2022 Sep; 28 (9):610-617 Epub 2022 June 22
    View PubMed
  37. Rosenthal A. Quality of Life and Survivorship in Lymphoma. Curr Oncol Rep. 2022 Sep; 24 (9):1113-1120 Epub 2022 Apr 08
    View PubMed
  38. Chhabra N, Cebak JE, Schmitt A, Lal D, Rosenthal AC, Taylor CM, Thorwarth RM, Shah AA, Rodriguez-Pla A. Concomitant presentation of eosinophilic or oncocytic mucoepidermoid carcinoma, immunoglobulin G4-related disease, and adult-onset asthma and periocular xanthogranuloma: Case report of 3 uncommon clinical entities. Medicine (Baltimore). 2022 Aug 12; 101 (32):e30067
    View PubMed
  39. Kuhlman JJ, Moustafa MA, Jiang L, Iqbal M, Seegobin K, Wolcott Z, Ayala E, Ansell S, Rosenthal A, Paludo J, Micallef I, Johnston P, Inwards D, Habermann T, Kharfan-Dabaja M, Witzig TE, Nowakowski GS, Tun HW. Leukemic High Grade B Cell Lymphoma is Associated With MYC Translocation, Double Hit/Triple Hit Status, Transformation, and CNS Disease Risk: The Mayo Clinic Experience. Clin Lymphoma Myeloma Leuk. 2022 Aug; 22 (8):e815-e825 Epub 2022 Apr 14
    View PubMed
  40. Alkhateeb HB, Mohty R, Greipp P, Bansal R, Hathcock M, Rosenthal A, Murthy H, Kharfan-Dabaja M, Bisneto Villasboas JC, Bennani N, Ansell SM, Patnaik MM, Litzow MR, He R, Chen D, Al-Kali A, Kenderian SS, Lin Y, Shah MV. Therapy-related myeloid neoplasms following chimeric antigen receptor T-cell therapy for Non-Hodgkin Lymphoma. Blood Cancer J 2022 Jul 26; 12 (7):113 Epub 2022 July 26
    View PubMed
  41. Chohan KL, Young JR, Lester S, Alhaj Moustafa M, Rosenthal A, Tun HW, Hoppe BS, Johnston PB, Micallef IN, Habermann TM, Ansell SM. A real-world study of combined modality therapy for early-stage Hodgkin lymphoma: too little treatment impacts outcome. Blood Adv. 2022 Jul 26; 6 (14):4241-4250
    View PubMed
  42. Zanwar S, Abeykoon JP, Dasari S, Ravindran A, Young JR, Acosta-Medina AA, Rech KL, Schwartz J, Mangold A, Rosenthal A, Bennani NN, Shah MV, Morlote D, Goyal G, Go RS. Clinical and therapeutic implications of BRAF fusions in histiocytic disorders. Blood Cancer J 2022 Jun 28; 12 (6):97 Epub 2022 June 28
    View PubMed
  43. Melody M, Gandhi S, Saunders H, Abdel-Rahman Z, Hastings J, Lengerke Diaz P, Gannon N, Truong T, Hathcock M, Khurana A, Johnston P, Ansell S, Bennani N, Paludo J, Bisneto JV, Wang Y, Rosenthal A, Foran J, Ayala E, Murthy HS, Roy V, Castro JE, Lin Y, Kharfan-Dabaja MA. Incidence of thrombosis in relapsed/refractory B-cell lymphoma treated with axicabtagene ciloleucel: Mayo Clinic experience. Leuk Lymphoma. 2022 Jun; 63(6):1363-1368. Epub 2022 Feb 03.
    View PubMed
  44. Gouni S, Rosenthal AC, Crombie JL, Ip A, Kamdar MK, Hess B, Feng L, Watson G, Ayers A, Neelapu SS, Khurana A, Lin Y, Iqbal M, Merryman RW, Strati P. A multicenter retrospective study of polatuzumab vedotin in patients with large B-cell lymphoma after CAR T-cell therapy. Blood Adv. 2022 May 10; 6 (9):2757-2762
    View PubMed
  45. Besch-Stokes JG, Costello CM, Severson KJ, Bhullar P, Montoya J, Butterfield RJ, DiCaudo DJ, Comfere N, Sluzevich J, Rule W, Craig FE, Rosenthal A, Pittelkow MR, Mangold AR. Primary cutaneous CD4(+) small/medium T-cell lymphoproliferative disorder: Diagnosis and management. J Am Acad Dermatol. 2022 May; 86 (5):1167-1169 Epub 2021 Apr 26
    View PubMed
  46. Iqbal M, Castano YG, Paludo J, Rosenthal A, Li Z, Beltran M, Moustafa MA, Inwards D, Porrata L, Micallef I, Bisneto JCV, Johnston P, Ansell SM, Reeder C, Murthy H, Roy V, Foran J, Tun HW, Kharfan-Dabaja MA, Ayala E. Impact of Cell of Origin on Outcomes After Autologous Hematopoietic Cell Transplant in Diffuse Large B-Cell Lymphoma. Clin Lymphoma Myeloma Leuk. 2022 Feb; 22 (2):e89-e95 Epub 2021 Aug 31
    View PubMed
  47. Gathers DA, Galloway E, Kelemen K, Rosenthal A, Gibson SE, Munoz J. Primary Effusion Lymphoma: A Clinicopathologic Perspective. Cancers (Basel). 2022 Jan 30; 14 (3)
    View PubMed
  48. Saifi O, Breen WG, Lester SC, Rule WG, Stish B, Rosenthal A, Munoz J, Herchko SM, Murthy HS, Lin Y, Bansal R, Hathcock MA, Bennani NN, Paludo J, Wang Y, Khurana A, Bisneto JCV, Johnston PB, Ansell SM, Iqbal M, Tun H, Ayala E, Kharfan-Dabaja MA, Hoppe BS, Peterson JL. Does bridging radiation therapy affect the pattern of failure after CAR T-cell therapy in non-Hodgkin lymphoma? Radiother Oncol. 2022 Jan; 166:171-179. Epub 2021 Dec 07.
    View PubMed
  49. Deshpande A, Rule W, Rosenthal A. Radiation and Chimeric Antigen Receptor T-cell Therapy in B-cell Non-Hodgkin Lymphomas. Curr Treat Options Oncol. 2022 Jan; 23 (1):89-98 Epub 2022 Feb 15
    View PubMed
  50. Francisco MT, Kaufman AE, Northfelt D, Padrnos L, Rosenthal AC, Andres J, Adamski J, Kinard T, Camoriano J. Relapsed refractory acquired thrombotic thrombocytopenic purpura (attp) following COVID-19 vaccination. Blood. 2021; 138(Suppl 1):4218.
  51. Severson KJ, Cumsky HJL, Brumfiel CM, Janeczek MC, Ginos BF, Kosiorek HE, Besch-Stokes J, Patel MH, Rule WG, DiCaudo DJ, Rosenthal AC, Pittelkow MR, Mangold AR. Blue light photodynamic therapy with 5-aminolevulinic acid in refractory mycosis fungoides: A prospective, open-label study. J Am Acad Dermatol 2021 Oct; 85 (4):969-971 Epub 2021 Jan 23
    View PubMed
  52. Brumfiel CM, Patel MH, Puri P, Besch-Stokes J, Lester S, Rule WG, Khera N, Sluzevich JC, DiCaudo DJ, Comfere N, Bennani NN, Rosenthal AC, Pittelkow MR, Mangold AR. How to Sequence Therapies in Mycosis Fungoides. Curr Treat Options Oncol. 2021 Sep 27; 22 (11):101 Epub 2021 Sept 27
    View PubMed
  53. Besch-Stokes JG, Patel MH, Brumfiel CM, Costello CM, Rule W, Rosenthal A, Pittelkow MR, DiCaudo DJ, Mangold AR. Cutaneous B cell pseudolymphoma treated with rituximab and methotrexate. Dermatol Online J. 2021 Sep 15; 27 (9) Epub 2021 Sept 15
    View PubMed
  54. Boudreaux BW, Patel MH, Brumfiel CM, Besch-Stokes J, DiCaudo DJ, Craig F, Rosenthal AC, Rule WG, Pittelkow MR, Mangold AR. Primary cutaneous epidermotropic marginal zone B-cell lymphoma treated with total skin electron beam therapy. JAAD Case Rep. 2021 Sep; 15:15-18 Epub 2021 July 13
    View PubMed
  55. Abeykoon JP, Zanwar S, Ansell SM, Muchtar E, He R, Greipp PT, King RL, Ailawadhi S, Paludo J, Larsen JT, Habermann TM, Inwards D, Go RS, Thanarajasingam G, Buadi F, Dispenzieri A, Thompson CA, Witzig TE, Lacy M, Gonsalves W, Nowakowski GS, Dingli D, Rajkumar SV, Kyle RA, Sher T, Roy V, Rosenthal A, Chanan-Khan AA, Reeder C, Gertz MA, Kumar S, Kapoor P. Assessment of fixed-duration therapies for treatment-naive Waldenstrom macroglobulinemia. Am J Hematol. 2021 Aug 1; 96 (8):945-953 Epub 2021 May 22
    View PubMed
  56. Gustafson MP, Wheatley-Guy CM, Rosenthal AC, Gastineau DA, Katsanis E, Johnson BD, Simpson RJ. Exercise and the immune system: taking steps to improve responses to cancer immunotherapy. J Immunother Cancer. 2021 Jul; 9 (7)
    View PubMed
  57. Singbartl K, Rosenthal A, Leis J, Patel B, Sen A. Novel Use of Extracorporeal Blood Purification for Treatment of Severe, Refractory Neurotoxicity After Chimeric Antigen Receptor T-Cell Therapy-A Case Report. Crit Care Explor. 2021 Jul; 3 (7):e0472 Epub 2021 June 29
    View PubMed
  58. Saifi O, Lester SC, Rule W, Stish BJ, Stafford S, Pafundi DH, Jiang L, Menke D, Moustafa MA, Rosenthal A, Sher T, Ernesto A, Tun HW, Hoppe BS, Peterson JL. Comparable Efficacy of Reduced Dose Radiation Therapy for the Treatment of Early Stage Gastric Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue. Adv Radiat Oncol. 2021 Jul-Aug; 6 (4):100714 Epub 2021 May 08
    View PubMed
  59. Melody M, Gandhi S, Rahman ZA, Lengerke-Diaz P, Gannon N, Rosenthal A, Truong T, Novo M, Brandes E, Lange G, Estby B, Johnston P, Ansell S, Bennani NN, Paludo J, Bisneto JV, Ayala E, Tun HW, Murthy HS, Roy V, Foran J, Castro J, Lin Y, Kharfan-Dabaja MA. Impact of hypoalbuminemia on the prognosis of relapsed/refractory B-cell lymphoma treated with axicabtagene ciloleucel. Eur J Haematol. 2021 Jul; 107 (1):48-53 Epub 2021 Apr 15
    View PubMed
  60. Galloway E, Griffith M, Rosenthal A. Multidisciplinary Management of Adolescent and Young Adult Patients with Hodgkin Lymphoma. Curr Treat Options Oncol. 2021 Jun 7; 22 (7):64 Epub 2021 June 07
    View PubMed
  61. Melody M, Rahman ZA, Saunders H, Diaz PL, Gannon N, Rosenthal A, Ayala E, Tun HW, Murthy H, Roy V, Foran J, Castro JE, Guru P, Kharfan-Dabaja MA. C-reactive protein and ferritin levels and length of intensive care unit stay in patients with B-cell lymphomas treated with axicabtagene ciloleucel. Hematol Oncol Stem Cell Ther. 2021 Jun; 14 (2):141-146 Epub 2020 Oct 13
    View PubMed
  62. Yang M, Rosenthal AC, Ashman JB, Craig FE. The Role and Pitfall of F18-FDG PET/CT in Surveillance of High Grade Pulmonary Lymphomatoid Granulomatosis. Curr Probl Diagn Radiol. 2021 May-Jun; 50 (3):443-449 Epub 2019 Feb 10
    View PubMed
  63. Breen ID, Brumfiel CM, Patel MH, Rosenthal AC, Rule WG, DiCaudo DJ, Craig FE, Pittelkow MR, Mangold AR. Mogamulizumab-induced interface dermatitis drug rash treated successfully with methotrexate and extracorporeal photopheresis in a patient with Sezary syndrome. JAAD Case Rep. 2021 Mar; 9:24-27 Epub 2021 Jan 12
    View PubMed
  64. Pophali PA, Larson MC, Rosenthal AC, Robinson D, Habermann TM, Thanarajasingam G, Call T, Allmer C, Farooq U, Maurer MJ, Yost KJ, Cerhan JR, Thompson CA. The association of health behaviors with quality of life in lymphoma survivors. Leuk Lymphoma. 2021 Feb; 62 (2):271-280 Epub 2020 Oct 13
    View PubMed
  65. Puri P, Severson KJ, Patel MH, Brumfiel CM, DiCaudo DJ, Rosenthal AC, Mangold AR. A case of B-cell lymphoblastic leukemia cutis flaring following CAR T-cell therapy in a patient with refractory acute lymphoblastic leukemia. JAAD Case Rep. 2021 Feb; 8:64-66 Epub 2020 Dec 17
    View PubMed
  66. Jin Z, Griffith MA, Rosenthal AC. Identifying and Meeting the Needs of Adolescents and Young Adults with Cancer. Curr Oncol Rep. 2021 Jan 15; 23 (2):17
    View PubMed
  67. Ramsower CA, Maguire A, Robetorye RS, Feldman AL, Syrbu SI, Rosenthal AC, Rimsza LM. Clinical laboratory validation of the MCL35 assay for molecular risk stratification of mantle cell lymphoma. J Hematop. 2020 Dec; 13 (4):231-238 Epub 2020 Oct 13
    View PubMed
  68. Teven CM, Rosenthal AC, Pockaj BA. Breast implant-associated anaplastic large cell lymphoma and the obligation of insurance providers. Breast J. 2020 Oct; 26 (10):2110-2111 Epub 2020 May 20
    View PubMed
  69. Staack SO, Rosenthal AC, Cook CB, Yang M. Glucocorticoid-Induced Hypermetabolism in White Adipose Tissue in Cushing Syndrome. J Nucl Med Technol. 2020 Sep; 48 (3):285-286 Epub 2019 Dec 06
    View PubMed
  70. Besch-Stokes JG, Costello CM, Bhullar PK, Maly CJ, Rosenthal AC, DiCaudo DJ, Pittelkow MR, Mangold AR. Regression of mycosis fungoides with large-cell transformation following skin biopsy. J Eur Acad Dermatol Venereol 2020 Feb; 34 (2):e82-e84 Epub 2019 Oct 28
    View PubMed
  71. Costello CM, Maly CJ, Snider S, Severson KJ, DiCaudo DJ, Rosenthal AC, Northfelt DW, Rule W, Craig FE, Pittelkow MR, Mangold AR. Immunosuppression-associated primary cutaneous plasmablastic lymphoma secondary to romidepsin. JAAD Case Rep. 2020 Jan; 6 (1):19-22 Epub 2019 Dec 24
    View PubMed
  72. Hilal T, Maguire A, Kosiorek HE, Rimsza LM, Rosenthal AC. Clinical features and cell of origin subtyping using gene expression profiling in HIV-negative patients with primary central nervous system lymphoma. Leuk Lymphoma 2019 Dec; 60 (14):3581-3583 Epub 2019 June 27
    View PubMed
  73. Yonan YA, Cumsky HJL, Costello CM, Maly CJ, Rosenthal AC, Reeder CB, Rule WG, Pittelkow MR, Craig FE, DiCaudo DJ, Mangold AR. Syringotropic and folliculotropic mycosis fungoides with mycosis fungoides-associated vasculopathic ulcers. JAAD Case Rep. 2019 Mar; 5 (3):231-233 Epub 2019 Feb 21
    View PubMed
  74. Robetorye RS, Ramsower CA, Rosenthal AC, Yip TK, Wendel Spiczka AJ, Glinsmann-Gibson BJ, Rimsza LM. Incorporation of Digital Gene Expression Profiling for Cell-of-Origin Determination (Lymph2Cx Testing) into the Routine Work-Up of Diffuse Large B-Cell Lymphoma. J Hematop. 2019 Mar; 12 (1):3-10 Epub 2019 Feb 14
    View PubMed
  75. Robetorye RS, Maguire A, Rosenthal AC, Rimsza LM. Profiling of lymphoma from formalin-fixed paraffin-embedded tissue. Semin Hematol. 2019 Jan; 56 (1):46-51 Epub 2018 May 28
    View PubMed
  76. Pophali PA, Ip A, Larson MC, Rosenthal AC, Maurer MJ, Flowers CR, Link BK, Farooq U, Feldman AL, Allmer C, Slager SL, Witzig TE, Habermann TM, Cohen JB, Cerhan JR, Thompson CA. The association of physical activity before and after lymphoma diagnosis with survival outcomes. Am J Hematol. 2018 Dec; 93 (12):1543-1550 Epub 2018 Oct 17
    View PubMed
  77. Thompson CA, Yost KJ, Maurer MJ, Allmer C, Farooq U, Habermann TM, Inwards DJ, Macon WR, Link BK, Rosenthal AC, Cerhan JR. Quality of life at diagnosis predicts overall survival in patients with aggressive lymphoma. Hematol Oncol. 2018 Dec; 36 (5):749-756 Epub 2018 June 03
    View PubMed
  78. Tung K, Rosenthal AC, Craig FE, Ashman JB, Yang M. Pitfall of (18)F-FDG PET/CT in Characterization of Relapsed Multisystem Lymphomatoid Granulomatosis. J Nucl Med Technol. 2018 Dec; 46 (4):396-397 Epub 2018 June 08
    View PubMed
  79. Rosenthal A, Rimsza L. Genomics of aggressive B-cell lymphoma. Hematology Am Soc Hematol Educ Program. 2018 Nov 30; 2018 (1):69-74
    View PubMed
  80. Hilal T, Wang Z, Almader-Douglas D, Rosenthal A, Reeder CB, Jain T. Rituximab maintenance therapy for mantle cell lymphoma: A systematic review and meta-analysis. Am J Hematol. 2018 Oct; 93 (10):1220-1226 Epub 2018 Sept 03
    View PubMed
  81. Asbury K, Seville MT, Pritt B, Scotch A, Rosenthal A, Grys TE, Kelemen K. The Brief Case: The Unexpected Souvenir. J Clin Microbiol. 2018 Sep; 56 (9) Epub 2018 Aug 27
    View PubMed
  82. Asbury K, Seville MT, Pritt B, Scotch A, Rosenthal A, Grys TE, Kelemen K. Closing the Brief Case: The Unexpected Souvenir. J Clin Microbiol 2018 Sep; 56 (9) Epub 2018 Aug 27
    View PubMed
  83. Sonbol MB, Hilal T, Dueck AC, Rosenthal AC, Conley CR, Kosiorek HE, Ginos BF, Gano KM, Nichols CS, Leis JF, Johnston PB, Habermann TM, Northfelt DW, Bergsagel PL, Inwards DJ, Witzig TE, Ansell SM, Reeder CB. A phase 2 study of rituximab, cyclophosphamide, bortezomib and dexamethasone (R-CyBorD) in relapsed low grade and mantle cell lymphoma. Leuk Lymphoma. 2018 Sep; 59(9):2128-2134. Epub 2018 Jan 10.
    View PubMed
  84. Raza HA, Nokes BT, Rosenthal AC, Mangold AR, Kelemen K, Jokerst CE, Cartin-Ceba R. Unicentric castleman disease complicated by paraneoplastic bronchiolitis obliterans and pemphigus. Respir Med Case Rep. 2018; 25:129-132 Epub 2018 Aug 10
    View PubMed
  85. Rosenthal A. Small Molecule Inhibitors in Chronic Lymphocytic Lymphoma and B Cell Non-Hodgkin Lymphoma. Curr Hematol Malig Rep. 2017 Jun; 12 (3):207-216
    View PubMed
  86. Rosenthal A, Dueck AC, Ansell S, Gano K, Conley C, Nowakowski GS, Camoriano J, Leis JF, Mikhael JR, Keith Stewart A, Stewart AK, Inwards D, Dingli D, Kumar S, Noel P, Gertz M, Porrata L, Russell S, Colgan J, Fonseca R, Habermann TM, Kapoor P, Buadi F, Leung N, Tiedemann R, Witzig TE, Reeder C. A phase 2 study of lenalidomide, rituximab, cyclophosphamide, and dexamethasone (LR-CD) for untreated low-grade non-Hodgkin lymphoma requiring therapy. Am J Hematol. 2017 May; 92 (5):467-472 Epub 2017 Mar 22
    View PubMed
  87. Rosenthal A, Younes A. High grade B-cell lymphoma with rearrangements of MYC and BCL2 and/or BCL6: Double hit and triple hit lymphomas and double expressing lymphoma. Blood Rev. 2017 Mar; 31 (2):37-42 Epub 2016 Sept 30
    View PubMed
  88. Pham M, Ressler S, Rosenthal A, Kelemen K. Classical Hodgkin lymphoma masquerading as chronic recurrent multifocal osteomyelitis: a case report. J Med Case Rep. 2017 Feb 18; 11 (1):45
    View PubMed
  89. Rosenthal A, Kumar S, Hofmeister C, Laubach J, Vij R, Dueck A, Gano K, Stewart AK. A Phase Ib Study of the combination of the Aurora Kinase Inhibitor Alisertib (MLN8237) and Bortezomib in Relapsed Multiple Myeloma. Br J Haematol 2016 Jul; 174 (2):323-5 Epub 2015 Sept 25
    View PubMed
  90. Coakley M, Yeneneh B, Rosenthal A, Fonseca R, Mookadam F. Extramedullary Cardiac Multiple Myeloma-A Case Report and Contemporary Review of the Literature. Clin Lymphoma Myeloma Leuk. 2016 May; 16: (5)246-52.
    View PubMed
  91. Rosenthal A, Luthi J, Belohlavek M, Kortum KM, Mookadam F, Mayo A, Fonseca R, Bergsagel PL, Reeder CB, Mikhael JR, Stewart AK. Carfilzomib and the cardiorenal system in myeloma: an endothelial effect? Blood Cancer J. 2016 Jan 15; 6 (1):e384
    View PubMed
  92. Rosenthal A, Mesa RA. Janus kinase inhibitors for the treatment of myeloproliferative neoplasms. Expert Opin Pharmacother. 2014 Jun; 15 (9):1265-76 Epub 2014 Apr 25
    View PubMed
  93. Campbell M, Rosenthal A, Kundranda M, Pickert A, Dicaudo D, Dogan A, Mikhael J. The blue man: a novel cutaneous manifestation of systemic amyloidosis. Amyloid. 2011 Sep; 18 (3):156-9 Epub 2011 Apr 20
    View PubMed